A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

Clinical trial NCT06963502 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06963502
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Colorectal Cancer Non-Small Cell Lung Cancer

Start date: 2025-05-30
Primary completion: 2028-12-31
Enrollment: 762

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.